Poland· PL-100332609
Cisatracurium Accord
A cisatracurium product containing cisatracurium, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cisatracurium is registered in 15 of 19 countries.
Countries holding a registration under ATC M03AC11 (cisatracurium), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Cisatracurium · ATC M03AC11
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Cisatracurium
- Manufacturer
- Accord Healthcare Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M03AC11
- ATC class
- Cisatracurium
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991202859
- gtin05909991202903
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for cisatracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cisatracurium · interactions on record
89 records
- 12 severe
- 44 moderate
- 4 minor
- 29 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cisatracurium in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCisatracurium Accord Healthcare 5 mg/mlAccord Healthcare
- SpainCISATRACURIO ACCORDPHARMA 5 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- FinlandCisatracurium AccordAccord Healthcare B.V.
- United StatesCisatracuriumFresenius Kabi USA, LLC
- CzechiaCISATRACURIUM KABIFresenius Kabi s.r.o., Praha
- United KingdomCisatracurium besilate 10mg/5ml solution for injection ampoulesAS Kalceks
- FranceCISATRACURIUM ACCORD 2 mg/ml, solution injectable/pour perfusionACCORD HEALTHCARE FRANCE
- NetherlandsCisatracurium Accord 2 mg/ml oplossing voor injectie of infusieAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Cisatracurium Accordpharma, Cisatracurium Hikma
- Belgium · Cisatracurium Fresenius Kabi, Cisatracurium Hikma
- Cyprus · Cisatracurium Accordpharma, Cisatral
- Czechia · Cisatracurium Kabi, Cisatracurium Kalceks
- Germany · Cisatracurium Hameln, Cisatracurium Hikma
- Denmark · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- Estonia · Cisatracurium Kalceks
- Spain · Cisatracurio Accordpharma, Cisatracurio Hikma
- Finland · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- France · Cisatracurium Accord, Cisatracurium Accordpharma
- United Kingdom (Northern Ireland) · Cisatracurium, Cisatracurium Accord Healthcare
- Greece · Cisatral
- Croatia · Cisatrakurij Accordpharma
- Hungary · Cisatracurium Accordpharma, Cisatracurium Kabi
- Ireland · Cisatracurium Kalceks, Cisatracurium Noridem Enterprises
- Italy · Cisatracurio Hikma, Cisatracurio Kalceks
- Lithuania · Cisatracurium Kalceks
- Luxembourg · Nimbex
- Latvia · Cisatracurium Kalceks
- Netherlands · Cisatracurium Accord, Cisatracurium Accordpharma
- Norway · Cisatracurium Accordpharma, Cisatracurium Kalceks
- Portugal · Cisatracúrio Accord, Cisatracúrio Accordpharma
- Romania · Cisatracurium Noridem
- Sweden · Cisatracurium Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9383094a-f2cb-4dcc-9733-de29f054d4ee GET /v1/drugs/9383094a-f2cb-4dcc-9733-de29f054d4ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań / do infuzji",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "05909991202859 ¦ Lz ¦ 105886\n1 fiol. 30 ml\n05909991202903 ¦ Lz ¦ 105891\n5 fiol. 30 ml",
"substance": "Cisatracurii besilas 6.7 mg",
"common_name": "Cisatracurium",
"pl_product_id": "100332609",
"pozwolenie_nr": "22238",
"auth_procedure": "DCP",
"authorisation_validity": "2024-03-19"
}See everything about cisatracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.